Skip to main content

Table 1 Pre-treatment characteristics of patients

From: GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells

Pre-treatment characteristics of patients, n = 21

Characteristic

Age

Median (yr)

61 (32–77)

Sex-no. (%)

Male

16 (76.2 %)

Female

5 (23.8 %)

ECOG performance status- no. (%)

0

18 (85.7 %)

1

3 (14.3 %)

Clinical staging (EUS/CT staging)

T1

0 (0 %)

T2

2 (9.5 %)

T3

17 (81.0 %)

T4

2 (9.5 %)

N0

7 (33.3 %)

N+

14 (66.7 %)

Histology grade

Moderately differentiated

3 (14.3 %)

Poorly differentiated

18 (85.7 %)